Rémi Bonjean: The 1st VHHs Against Active Rap1 to Monitor Platelet Activation
Rémi Bonjean, R and D Project Manager at Nanomunity, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I share with you the work we have done in collaboration with the Pr Marie-Christine Alessi from Cardiovascular and Nutrition Research Center – (C2VN) and Dr Patrick Chames in the article ‘Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers’ a method article published in the journal Research and Practice in Thrombosis and Haemostasis.
In this article, we successfully developed, produced the first generation of VHHs against active Rap1 as promising tools to quantify active Rap1 levels in platelets and facilitate clinical studies to monitor platelet Rap1 activation in various medical contexts.
I would like to thank all authors who contributed to this collaboration especially Pr Marie-Christine Alessi, Dr Patrick Chames, Dr Maxime Moulard and Marielle Margier.”
Title: Selection and optimization strategy for Rap1-targeting single-domain antibodies as platelet activation markers
Authors: Marie-Christine Alessi, Maxime Moulard, Daniele Boulay-Moine, Cyril Pons, Marielle Margier, Cléa Vessière, Marjorie Poggi, Theo Pigaglio, Francoise Dignat-George, Alain Roussel, Stéphane Burtey, Laurent Bonello, Patrick Chames, Remi Bonjean, Franck Peiretti
Read the Full Article on RPTH Journal
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE